Hannah Joseph Hospital Limited has revised its intimation regarding the upcoming Board of Directors meeting scheduled to be held on Friday, May 29, 2026. The meeting will take place at the company's Corporate Office located at R.S. No. 115/3B2, 116/1A2, Madurai–Tuticorin Ring Road, Chinthamani, Madurai – 625009. The notification has been filed pursuant to Regulation 29(1)(a) and Regulation 29(1)(e) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting Agenda

The board meeting has been convened to consider and approve the audited financial results of the company for the half year and financial year ended March 31, 2026. Additionally, the board will consider the recommendation of a final dividend, if any, on equity shares for the financial year ended March 31, 2026. The key details of the scheduled meeting are outlined below:

Trading Window Closure

In accordance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, and the company's Code of Conduct for Prevention of Insider Trading, Hannah Joseph Hospital Limited has enforced a trading window closure. The restriction applies to Directors, Designated Persons, and their immediate relatives.

• Trading window closed with effect from: April 1, 2026
• Trading window to remain closed until: 48 (Forty-Eight) hours after the declaration of the audited financial results

The revised intimation was signed by Dr. Mosesjoseph Arunkumar, Managing Director (DIN: 03608603), on May 21, 2026. The company operates as an Institute of Neurosciences, Cardiac Sciences, Orthopaedics & Traumatology and holds NABH accreditation.

Hannah joseph hospital Limited has fulfilled its quarterly compliance requirements by submitting a certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The healthcare provider, which operates as an institute specializing in neurosciences, cardiac sciences, orthopaedics and traumatology, filed the necessary documentation with BSE Limited on April 09, 2026.

Regulatory Compliance Details

The certificate was issued by BTS Consultancy Services Private Limited, serving as the company's Registrar and Share Transfer Agents. The document confirms that Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 is not applicable to Hannah Joseph Hospital Limited, as the entire holding of the company's equity shares are maintained in demat form.

Company Information

Hannah Joseph Hospital Limited operates with its registered office located at 134, Lake View Road, K.K.Nagar, Madurai - 625 020, Tamil Nadu. The company's corporate office is situated at R.S. No: 115/3B2 116/1A2, Madurai-Tuticorin Ring Road, Chinthamani, Madurai - 625 009, Tamil Nadu. The healthcare facility holds NABH accreditation and operates NABL accredited laboratories.

Compliance Framework

The submission was signed by CS Yuvaraj Saravanan, Company Secretary & Compliance Officer, who holds ICSI Membership No.: A66149. The digital signature was applied on April 09, 2026, at 14:23:27 +05'30'. This quarterly filing represents part of the company's ongoing regulatory compliance obligations under SEBI guidelines for listed entities.

The certificate from BTS Consultancy Services confirms the company's adherence to modern share holding practices, with all equity shares maintained in electronic format through the depository system, eliminating the need for physical share certificates and ensuring efficient transfer mechanisms.